Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

An earnings beat, a sales miss, and future guidance all went awry.

Why Owens & Minor Stock Just Dropped 22.5%

Owens & Minor (OMI) delivered earnings and revenue surprises of 9.09% and -12.14%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Surpasses Q4 Earnings Estimates

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Owens & Minor (OMI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Accuray

CareDx

Smith Micro Software

Synaptics

Vista Outdoor

President Trump's tenure has seen Wall Street perform exceptionally well so far. In fact, Trump often cites Wall Street's bull run as a reflection of his good governance.

Trump Mulling Tax Cuts to Incentivize Stock Buying? 6 Picks

Community Health Systems

Cytokinetics

Endo International

Momenta Pharmaceuticals

The small-cap healthcare companies are benefiting from the 2020 presidential election campaign, which has put pressure on the large cap cousins on how to overhaul the industry.

Small-Cap Healthcare ETF Outperforming in 2020: 5 Top Stocks

American Airlines

AmerisourceBergen

ArcBest

Commercial Metals

The guidance to design a winning portfolio comes from brokers. Given their thorough know-how pertaining to the stock market, investors often look to be guided by broker advice.

5 Stocks That Look Impressive After Broker Rating Upgrades

Costco

Delta Air Lines

EOG Resources

JELD-WEN Hld

After an in-depth research, brokers decide to rate a company's stock. Thus, when they upgrade a stock, you can easily rely on it.

Buy These 5 Top-Ranked Stocks With Upgraded Broker Ratings

Baird applauds moves to restructure and cut debt.

Why Owens & Minor Stock Popped Another 14% Today

The healthcare solutions company sells a division, and collects a bit of cash.

Why Owens & Minor Stock Popped 11% Today

We believe that Owens & Minor (OMI) is a secular short with 70-100% downside over the next 12-18 months.

Owens & Minor: Over-Leveraged Balance Sheet And Secularly Declining Earnings Power

Owens & Minor, Inc. (OMI) CEO Ed Pesicka on Q3 2019 Results - Earnings Call Transcript

Owens & Minor (OMI) delivered earnings and revenue surprises of 15.79% and -1.62%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Tops Q3 Earnings Estimates

As of late, it has definitely been a great time to be an investor Owens & Minor.

Will Owens & Minor Continue to Surge Higher?

Let's see if Owens & Minor, Inc. (OMI) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Is Owens & Minor (OMI) a Suitable Stock for Value Investors?

A big earnings beat helped this technology supplier today.

Why Owens & Minor's Shares Popped 20.1% Today

Owens & Minor, Inc. (OMI) CEO Ed Pesicka on Q2 2019 Results - Earnings Call Transcript

Owens & Minor (NYSE: OMI) reported second-quarter earnings of 10 cents per share, which beat the analyst consensus estimate of 7 cents by 42.86%.

Owens & Minor Reports Q2 Earnings Beat

Owens & Minor (OMI) delivered earnings and revenue surprises of 42.86% and 2.35%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Q2 Earnings and Revenues Top Estimates

Owens & Minor, Inc. (OMI) CEO Ed Pesicka on Q1 2019 Results - Earnings Call Transcript

Owens & Minor (OMI) delivered earnings and revenue surprises of -50.00% and -0.86%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

News for Owens & Minor Stock (OMI)